Corrigendum to "The tyrosine kinase inhibitor, sunitinib malate, induces cognitive impairment in vivo via dysregulating VEGFR signaling, apoptotic and autophagic machineries" [Experimental Neurology, 283 (2016) 129-141]
- PMID: 36707333
- DOI: 10.1016/j.expneurol.2023.114328
Corrigendum to "The tyrosine kinase inhibitor, sunitinib malate, induces cognitive impairment in vivo via dysregulating VEGFR signaling, apoptotic and autophagic machineries" [Experimental Neurology, 283 (2016) 129-141]
Erratum for
-
The tyrosine kinase inhibitor, sunitinib malate, induces cognitive impairment in vivo via dysregulating VEGFR signaling, apoptotic and autophagic machineries.Exp Neurol. 2016 Sep;283(Pt A):129-41. doi: 10.1016/j.expneurol.2016.06.004. Epub 2016 Jun 7. Exp Neurol. 2016. PMID: 27288242
Publication types
LinkOut - more resources
Full Text Sources